Project GAPVAC – Glioma Actively Personalized Vaccine Consortium / CIMT partner
Glioma Actively Personalized Vaccine Consortium / CIMT partner
01/11/2012 to 01/11/2016
Abstract / short description:
The Glioma Actively Personalized VAccine Consortium (GAPVAC) is the first EU-funded initiative aimed at clinically developing biomarker-guided actively personalized vaccines (APVACs) to treat cancer patients.
Local organizational units
Interfaculty Institute for Cell Biology (IFIZ)